A Multifaceted Disease Of Problematic Diagnosis in Childhood: Hereditary Hemorrhagic Telangiectasia: A Case Report

BackgroundHereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia which is inherited in an autosomal dominant manner and may involve skin, mucosa and internal organs. HHT can cause arteriovenous, arterioportal, and portovenous shunts in the liver, resulting in cirrhosis and portal hypertension. Case PresentationAn 8-year-old male patient with a diagnosis of myelodysplastic syndrome for 2 years was admitted with melena.Portal doppler ultrasonography showed a heterogeneous appearance of the liver parenchyma and 14 cm splenomegaly with no portal hypertension. An extended etiological investigation for chronic liver disease was conducted. Afterliver biopsy, the patient’s general condition deteriorated, with abdominal distension and reduced hematocrit. The Doppler and hepatic angiography findings together with the history of recurrent episodes of epistaxis led us to the diagnosis of HHT. He was referred to the transplant center for liver transplantation due to the irreversible bleeding from the liver. ConclusionHepatic telangiectasias may be present in patients with uncontrollable bleeding after liver biopsy who do not have any hematologic disorders.

[1]  M. Poulsen,et al.  High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment , 2020, Orphanet Journal of Rare Diseases.

[2]  C. Olivieri,et al.  Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes , 2013, Genetics in Medicine.

[3]  A. Chavan,et al.  Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT). , 2013, VASA. Zeitschrift fur Gefasskrankheiten.

[4]  V. Lund,et al.  Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia. , 2012, Rhinology.

[5]  A. Davenport,et al.  Critical care issues in patients after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  G. Garcia‐Tsao Liver involvement in hereditary hemorrhagic telangiectasia (HHT). , 2007, Journal of hepatology.

[7]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[8]  M. Manns,et al.  Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT) , 2003, Hepatology.

[9]  Liang‐Kung Chen,et al.  Hereditary hemorrhagic telangiectasia. , 2020, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[10]  Erkan Alpsoy,et al.  Bir Herediter Hemorajik Telanjiektazi Olgusu , 1995 .

[11]  H. Plauchu,et al.  Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. , 1989, American journal of medical genetics.